跳至主要内容
临床试验/NCT01133223
NCT01133223撤回2 期

Randomized Clinical Trial Comparing Intravenous Thrombolysis With Thrombectomy by the Penumbra™ System in Patients With Middle Cerebral Artery Stem Occlusion - Pilot Study

Hospital de Clinicas de Porto Alegre1 个研究点 分布在 1 个国家开始时间: 2010年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
撤回
试验地点
1
主要终点
Functional independence (modified Rankin Scale 0-2)

研究概览

简要总结

Stroke prognosis is intimately related to reperfusion. Reperfusion in acute setting can be achieved with different strategies - varying from intravenous rtPA from mechanical thrombectomy. Recently, interventional approaches have been gaining attention and playing an increasing role in stroke care. However, no solid scientifical data is available to date. The investigators want do conduct a pilot trial to test if the use of the Penumbra™ System can improve clinical outcomes in a specific stroke setting.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Patient enrolled in acute ischemic stroke protocol
  • Up to 3,5h from symptoms onset
  • Clinical findings compatible with middle cerebral artery syndrome
  • Angiotomographic evidence of proximal middle cerebral artery occlusion

排除标准

  • NIHSS < 10
  • Overt contraindication to thrombolysis or angiopgraphy
  • Disagreement with informed consent term or refusal to participate

研究组 & 干预措施

Thrombectomy

Active Comparator

干预措施: Penumbra™ System (Device)

Usual Care

Active Comparator

干预措施: Recombinant tissue plasminogen activator (Drug)

结局指标

主要结局

Functional independence (modified Rankin Scale 0-2)

时间窗: 3 months

次要结局

  • Minimal or no disability (modified Rankin Scale 0-1)(3 months)
  • Overall mortality(7 days and 3 months)
  • Symptomatic cerebral bleeding rate(48 hours, 7 days and 3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lucas Scotta Cabral

Lucas Scotta Cabral

Hospital de Clinicas de Porto Alegre

研究点 (1)

Loading locations...

相似试验